CVKD Stock Summary and Trading Ideas (Cadrenal Therapeutics | NASDAQ:CVKD)

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.

What symbol and exchange does Cadrenal Therapeutics shares trade?

Cadrenal Therapeutics trades on the NASDAQ stock market under the symbol CVKD.

What is Cadrenal Therapeutics stock price doing today?

As of April 16, 2026, CVKD stock price climbed to $4.85 with 29,607 million shares trading.

What is Cadrenal Therapeutics's Beta?

CVKD has a beta of 1.30, meaning it tends to be more sensitive to market movements. CVKD has a correlation of 0.05 to the broad based SPY ETF.

How much is Cadrenal Therapeutics worth?

CVKD has a market cap of $11.34 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Cadrenal Therapeutics traded in the last 3 year period?

In the last 3 years, CVKD traded as high as $47.10 and as low as $4.21.

What are the top ETFs holding Cadrenal Therapeutics?

The top ETF exchange traded funds that CVKD belongs to (by Net Assets): VTI, VXF, IWC, DFSU.

Is Cadrenal Therapeutics (CVKD) a good investment?

CVKD has underperformed the market in the last year with a price return of -70.3% while the SPY ETF gained +31.9%. CVKD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.9% and -1.0%, respectively, while the SPY returned +1.6% and +7.1%, respectively.

What are the support and resistance levels for Cadrenal Therapeutics (CVKD)?

CVKD support price is $4.44 and resistance is $5.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVKD shares will trade within this expected range on the day.